Media Summary: Alice Shaw, MD, PhD, and Tony Mok, MD, provide insight on the role of Corey J. Langer, MD, discusses the use of Tianhong (Tina) Li, MD, PhD, assistant professor, co-director of Phase I Program, UC Davis Cancer Center, mentions there are ...

Mutation Testing To Guide Alk - Detailed Analysis & Overview

Alice Shaw, MD, PhD, and Tony Mok, MD, provide insight on the role of Corey J. Langer, MD, discusses the use of Tianhong (Tina) Li, MD, PhD, assistant professor, co-director of Phase I Program, UC Davis Cancer Center, mentions there are ... Shirish Gadgeel, MD, explains the importance of repeat Jonathan W. Riess, MD, MS, determines the value of repeat Geoffrey R. Oxnard, MD, and Sandip Patel, MD, discuss the use of plasma-based genetic profiling of EGFR and

Sarah Goldberg, MD, describes the role of In this first video in a two-part series, join Jordan Leven as he explains what Discuss personal approaches to therapeutic sequencing strategies for Learn more about lung cancer at Robert Winn, MD, director of Virginia Commonwealth ...

Photo Gallery

Mutation Testing to Guide ALK TKI Selection in NSCLC
Mutation Testing at Progression of ALK-Rearranged NSCLC
Dr. Li Discusses ALK Gene Mutation Tests
Repeat Mutation Testing at ALK-Rearranged NSCLC Progression
Value of Repeat Mutation Testing for ALK+ NSCLC
Plasma Testing for NSCLC EGFR & ALK Mutations
ALK Gene Alterations and Genomic Testing(Podcast)
Mutation Testing in NSCLC
Calling All Mutants: Getting Started with Mutation Testing
Sequencing Strategies for ALK-Targeted Therapy
ALK Mutations in Lung Cancer - Lung Cancer Foundation of America
What targeted therapies are used for people with the ALK mutation?
View Detailed Profile
Mutation Testing to Guide ALK TKI Selection in NSCLC

Mutation Testing to Guide ALK TKI Selection in NSCLC

Alice Shaw, MD, PhD, and Tony Mok, MD, provide insight on the role of

Mutation Testing at Progression of ALK-Rearranged NSCLC

Mutation Testing at Progression of ALK-Rearranged NSCLC

Corey J. Langer, MD, discusses the use of

Dr. Li Discusses ALK Gene Mutation Tests

Dr. Li Discusses ALK Gene Mutation Tests

Tianhong (Tina) Li, MD, PhD, assistant professor, co-director of Phase I Program, UC Davis Cancer Center, mentions there are ...

Repeat Mutation Testing at ALK-Rearranged NSCLC Progression

Repeat Mutation Testing at ALK-Rearranged NSCLC Progression

Shirish Gadgeel, MD, explains the importance of repeat

Value of Repeat Mutation Testing for ALK+ NSCLC

Value of Repeat Mutation Testing for ALK+ NSCLC

Jonathan W. Riess, MD, MS, determines the value of repeat

Plasma Testing for NSCLC EGFR & ALK Mutations

Plasma Testing for NSCLC EGFR & ALK Mutations

Geoffrey R. Oxnard, MD, and Sandip Patel, MD, discuss the use of plasma-based genetic profiling of EGFR and

ALK Gene Alterations and Genomic Testing(Podcast)

ALK Gene Alterations and Genomic Testing(Podcast)

Discover in-depth knowledge about

Mutation Testing in NSCLC

Mutation Testing in NSCLC

Sarah Goldberg, MD, describes the role of

Calling All Mutants: Getting Started with Mutation Testing

Calling All Mutants: Getting Started with Mutation Testing

In this first video in a two-part series, join Jordan Leven as he explains what

Sequencing Strategies for ALK-Targeted Therapy

Sequencing Strategies for ALK-Targeted Therapy

Discuss personal approaches to therapeutic sequencing strategies for

ALK Mutations in Lung Cancer - Lung Cancer Foundation of America

ALK Mutations in Lung Cancer - Lung Cancer Foundation of America

ALK

What targeted therapies are used for people with the ALK mutation?

What targeted therapies are used for people with the ALK mutation?

Learn more about lung cancer at http://www.YouAndLungCancer.com Robert Winn, MD, director of Virginia Commonwealth ...

Mutation Testing

Mutation Testing

Cathy Eng says